Galectin 1 hFc Chimera, Mouse
Galectin 1 HFc Chimera, Mouse

The purity of Galectin 1 hFc Chimera, Mouse is greater than 95% as determined by SEC-HPLC.

Galectin 1 HFc Chimera, Mouse

Galectin 1 hFc Chimera, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

Galectin 1 hFc Chimera, Mouse

Galectin 1(Gal-1), a β-galactoside binding mammalian lectin of 14KDa, is implicated in many signalling pathways, immune responses associated with cancer progression and immune disorders. Inhibition of human Gal-1 has been regarded as one of the potential therapeutic approaches for the treatment of cancer, as it plays a major role in tumour development and metastasis by modulating various biological functions viz. apoptosis, angiogenesis, migration, cell immune escape.
Z06132
¥63,425.00

Ask us a question
Product Introduction
Species Mouse
Protein Construction
hFc Galectin 1 (Ala2-Glu135)_x000D_
Accession # P16045
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 42 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 45-52 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • Galectin 1 HFc Chimera, Mouse
    • Galectin 1 HFc Chimera, Mouse

    The purity of Galectin 1 hFc Chimera, Mouse is greater than 95% as determined by SEC-HPLC.

  • Galectin 1 HFc Chimera, Mouse
    • Galectin 1 HFc Chimera, Mouse

    Galectin 1 hFc Chimera, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background Galectin 1(Gal-1), a β-galactoside binding mammalian lectin of 14KDa, is implicated in many signalling pathways, immune responses associated with cancer progression and immune disorders. Inhibition of human Gal-1 has been regarded as one of the potential therapeutic approaches for the treatment of cancer, as it plays a major role in tumour development and metastasis by modulating various biological functions viz. apoptosis, angiogenesis, migration, cell immune escape.
Synonyms Galectin-1; HLBP14; S-Lac lectin 1; LGALS1; GAL1; GBP; DKFZp686E23103; Galectin 1

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.